In a recent trial, Sindher’s team found that the injectable medication omalizumab reduces the risk of allergic reactions. Omalizumab is now FDA-approved for children one year and older, either alone ...

He has had no issue taking the injections but now he knows what’s coming and bounces around too much for me to give him an injection.

Great. Thank you for coming, everybody. I'm James Gordon, Barclays European pharma and biotech analyst. And today, I've got the pleasure of hosting a fireside with GSK. So we're going to hear from GSK ...

We chose the best dog foods with guidance from veterinarians. Our top picks include dry, wet, and fresh food for adults, ...

Dust mites - measuring about a quarter of a millimetre long and invisible to the human eye - are the bane of many people's lives.

A 2026 consumer information report examining Orivelle Fungus Pen marketing claims, tea tree oil ingredient research context, side effects and tolerability questions, 'is it legit' verification ...

Simranjit Kaur told Newsweek she thought she may have had gluten intolerance when symptoms started, but she never imagined cancer.

Individuals with one to three allergenic foods are able to introduce and continue eating allergenic foods at 12 months after multifood oral immunotherapy (mOIT) or omalizumab, according to a study ...

At AAAAI 2026, Robert Wood, MD, of Johns Hopkins University School of Medicine, discusses the use of omalizumab vs OIT for treating food allergy.

More adults with IgE-mediated peanut allergy receiving remibrutinib vs. placebo for 4 weeks tolerated a single dose of at least 600 mg peanut protein without dose-limiting symptoms, according to a ...

In little moments like when sipping coffee or licking an ice cream cone, it doesn't seem like your body is pulling off a biological miracle. But it is. That cookie is not you—yet when you put it in ...